DORMA increases sales by 7.8 percent to €700 million

Return to organic growth despite difficult market environment

Düsseldorf/Ennepetal. Having achieved an increase in sales of 7.8% to around €700 million (previous year: €649 million), the DORMA Group made an impressive return to growth in fiscal 2004/05 (30 June). Encouragingly for the company, this rise is attributable to a reasonably equal split between organic growth ( 5.1%) and growth from acquisitions ( 4.2%) after adjusting for a negative foreign exchange impact (-1.5%). Speaking at the annual press conference held in Düsseldorf to report DORMA’s results, CEO Dr. Michael Schädlich announced the following numbers: Earnings before interest and taxes on income (EBIT) produced a return on sales of 6.5%, falling just short of the 7.4% achieved in the previous year. Before exceptional items, EBIT for the fiscal year amounted to €55 million (previous year: €51.6 million), giving an adjusted return on sales of 7.9% to match that of fiscal 2003/04. “Operating profit has thus kept pace with our growth in sales,” Dr. Schädlich underlined.

Markets abroad again the main growth drivers
Despite the persistent sluggishness encountered in DORMA’s core German market, the company generated an increase in domestic sales of 2%. However, the main source of improving revenues was once again its international market which now accounts for more than 70% of total Group sales. more…

back

Text download

Press release as wordfile

Picture download:
	DORMA Sales Volume download view picture
	Karl-Rudolf Mankel - Proprietor DORMA Group download view picture
	Dr. Michael Schädlich - CEO DORMA Group download view picture